Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sarcolemmal KATP channel modulators and cardiac arrhythmias.
Baczkó I, Husti Z, Lang V, Leprán I, Light PE. Baczkó I, et al. Curr Med Chem. 2011;18(24):3640-61. doi: 10.2174/092986711796642472. Curr Med Chem. 2011. PMID: 21774762 Review.
ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.
Leprán I, Baczkó I, Varró A, Papp JG. Leprán I, et al. Among authors: baczko i. J Pharmacol Exp Ther. 1996 Jun;277(3):1215-20. J Pharmacol Exp Ther. 1996. PMID: 8667181
Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats.
Baczkó I, Leprán I, Papp JG. Baczkó I, et al. J Cardiovasc Pharmacol. 1997 Feb;29(2):196-201. doi: 10.1097/00005344-199702000-00007. J Cardiovasc Pharmacol. 1997. PMID: 9057068
KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Baczkó I, Leprán I, Papp JG. Baczkó I, et al. Eur J Pharmacol. 1997 Apr 11;324(1):77-83. doi: 10.1016/s0014-2999(97)00064-2. Eur J Pharmacol. 1997. PMID: 9137916
Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.
El-Reyani NE, Bozdogan O, Baczkó I, Leprán I, Papp JG. El-Reyani NE, et al. Among authors: baczko i. Eur J Pharmacol. 1999 Jan 22;365(2-3):187-92. doi: 10.1016/s0014-2999(98)00866-8. Eur J Pharmacol. 1999. PMID: 9988102
Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
Baczkó I, El-Reyani NE, Farkas A, Virág L, Iost N, Leprán I, Mátyus P, Varró A, Papp JG. Baczkó I, et al. Eur J Pharmacol. 2000 Sep 15;404(1-2):181-90. doi: 10.1016/s0014-2999(00)00591-4. Eur J Pharmacol. 2000. PMID: 10980278
Plasma membrane KATP channel-mediated cardioprotection involves posthypoxic reductions in calcium overload and contractile dysfunction: mechanistic insights into cardioplegia.
Baczkó I, Jones L, McGuigan CF, Manning Fox JE, Gandhi M, Giles WR, Clanachan AS, Light PE. Baczkó I, et al. FASEB J. 2005 Jun;19(8):980-2. doi: 10.1096/fj.04-3008fje. Epub 2005 Mar 16. FASEB J. 2005. PMID: 15774423
Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
Lengyel C, Varró A, Tábori K, Papp JG, Baczkó I. Lengyel C, et al. Among authors: baczko i. Br J Pharmacol. 2007 Aug;151(7):941-51. doi: 10.1038/sj.bjp.0707297. Epub 2007 May 29. Br J Pharmacol. 2007. PMID: 17533421 Free PMC article.
Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S, Baczkó I, Leprán I. Vajda S, et al. Among authors: baczko i. Eur J Pharmacol. 2007 Dec 22;577(1-3):115-23. doi: 10.1016/j.ejphar.2007.08.016. Epub 2007 Aug 19. Eur J Pharmacol. 2007. PMID: 17904545
Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?
Jost N, Acsai K, Horváth B, Bányász T, Baczkó I, Bitay M, Bogáts G, Nánási PP. Jost N, et al. Among authors: baczko i. Basic Res Cardiol. 2009 Jan;104(1):33-41. doi: 10.1007/s00395-008-0730-3. Epub 2008 Jul 5. Basic Res Cardiol. 2009. PMID: 18604626
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback